Incyte Corp

NASDAQ: INCY
$78.59
+$1.52 (+2.0%)
Closing price April 3, 2020
Thursday's top analyst upgrades, downgrades and initiations included Alibaba, Annaly Capital Management, Bed Bath & Beyond, Clorox, CrowdStrike, FireEye, GoPro, Lyft, Square, Tesla and Uber...
Jon C. Ogg
Monday's top analyst upgrades, downgrades and initiations included Apple, Bed Bath & Beyond, Chico's FAS, Clorox, Deere, Gap, Newell Brands, RealReal, Teva Pharmaceutical, UnitedHealth and Wells...
Jon C. Ogg
The top analyst upgrades, downgrades and initiations seen on Friday included American Express, Bristol-Myers Squibb, Celgene, CognizantTechnology Solutions, Electronic Arts, Fortinet, Lyft, Target,...
Jon C. Ogg
The top analyst upgrades, downgrades and initiations seen on Thursday included Apple, Chipotle Mexican Grill, CEMEX, CVS, Eli Lilly, Hewlett Packard Enterprise, IBM, Incyte, MercadoLibre and U.S....
Jon C. Ogg
The biotech team at SunTrust feel that it would not be a major surprise to see these six top companies post quarterly results that beat top-line Wall Street expectations.
Lee Jackson
The top analyst upgrades, downgrades and initiations seen on Wednesday included Apache, Caesars Entertainment, Dell Technologies, Devon Energy, Hewlett Packard Enterprise, NetApp, Nordstrom, MetLife...
Jon C. Ogg
Thursday was a down day for the broad U.S. markets, with each of the major indices notching a loss in the session. The Nasdaq took the worst of it seeing one of its worst days in 2018. Crude oil...
Chris Lange
Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in September.
Chris Lange
The top analyst upgrades, downgrades and other research calls from Wednesday include AutoZone, Chipotle Mexican Grill, Diamondback Energy, Hasbro, Papa John’s and Western Digital.
Lee Jackson
These are five stocks that the top hedge funds are buying, none of which is an overbought and crowded tech stock. They all make good sense for growth accounts with some risk tolerance.
Lee Jackson
The include top analyst upgrades, downgrades and other research calls from Wednesday Akamai Technologies, Apple, AutoZone, Dropbox, Electronic Arts, Ford, Kinder Morgan, Pandora Media, Procter &...
Jon C. Ogg
Tuesday was a positive day for the broad U.S. markets with each of the major exchanges recovering, if only slightly, from Monday. Crude oil was pushed much higher in the session, retreating over $70....
Chris Lange
Incyte and Eli Lilly will be under the microscope next week as the FDA will decide the fate of their rheumatoid arthritis treatment.
Chris Lange
Thursday was another positive day for the broad U.S. markets. Although markets were solid throughout the day, there was a small dip at the end from some selling pressure. At the same time, crude oil...
Chris Lange
Acadia Pharmaceuticals, Veo, Sibanye Gold, and Incyte Pharmaceuticals all posted new 52-week lows Monday.
Paul Ausick